Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells
- 8 May 2003
- journal article
- Published by Springer Nature in Oncogene
- Vol. 22 (18) , 2795-2804
- https://doi.org/10.1038/sj.onc.1206399
Abstract
Downregulation of proapoptotic molecules like Fas or caspase 8, or upregulation of antiapoptotic molecules like FLICE inhibitory protein has been suggested to be a regulatory mechanism set up by tumor cells to block the death signal received via death receptors. In an in-depth study of the Fas/FasL-signaling pathway in thyroid tumor development, we have demonstrated that tumor cells specifically downregulate the multideath receptor adapter Fas-associated death domain (FADD). The regulation of FADD expression occurred only at the protein level. Furthermore, in the absence of FADD, Fas-signaling resulted in accelerated growth of thyrocytes. Since thyrocytes also acquired FasL expression during tumor development, the absence of FADD protein could lead to greater resistance to numerous death receptor-mediated apoptosis, stimulation of their own proliferation through Fas/FasL interaction, and the capacity to counter-attack the infiltrating lymphocytes.Keywords
This publication has 44 references indexed in Scilit:
- Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalizationOncogene, 2001
- Thyroid-stimulating Hormone and Cyclic AMP Activate p38 Mitogen-activated Protein Kinase CascadeJournal of Biological Chemistry, 2000
- eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of TranslationAnnual Review of Biochemistry, 1999
- FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of ApoptosisScience, 1998
- Apoptosis by Death FactorCell, 1997
- Fas Signal Transduction Triggers Either Proliferation or Apoptosis in Human FibroblastsJournal of Investigative Dermatology, 1997
- Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling PathwaysScience, 1997
- Expression of APO‐1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epitheliumInternational Journal of Cancer, 1994
- Fas/APO-1 Expression and Function on Malignant Cells of Hematologic and Nonhematologic OriginJournal of Immunotherapy, 1993
- Complete Development of Hepatic Stages of Plasmodium falciparum in VitroScience, 1985